The effect of switch therapy to tenofovir versus entecavir maintenance on recurrence of hepatocellular carcinoma after surgery (SWITE): study protocol for a randomized controlled trial

BACKGROUND: Antiviral therapy has been reported to be associated with lower recurrence rate of hepatocellular carcinoma (HCC) for patients with hepatitis B virus (HBV) infection. While entecavir (ETV) and tenofovir disoproxil fumarate (TDF) were both recommended as first-line therapies for HBV patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Wei, Yi, Mengshi, Qi, Xin, Qi, Weili, Li, Chuan, Wen, Tianfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693690/
https://www.ncbi.nlm.nih.gov/pubmed/38042834
http://dx.doi.org/10.1186/s13063-023-07822-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693690/
https://www.ncbi.nlm.nih.gov/pubmed/38042834
http://dx.doi.org/10.1186/s13063-023-07822-y

Ejemplares similares